sifin diagnostics
Private Company
Funding information not available
Overview
sifin diagnostics is a well-established, privately-held German diagnostics manufacturer with a 30+ year history. The company operates in the niche but critical field of blood group serology and broader microbiological testing, producing monoclonal antibodies, bacterial test reagents, culture media, and immunoassays. It maintains key ISO certifications (9001, 13485, 17025) for quality and manufacturing, indicating a focus on regulated markets. Its business model is purely diagnostic, generating revenue through the global sale of its products and contract manufacturing services.
Technology Platform
Hybridoma technology for monoclonal antibody production, with expertise in immunology and microbiology assay development for in-vitro diagnostics.
Opportunities
Risk Factors
Competitive Landscape
sifin diagnostics operates in a competitive global IVD market dominated by giants like Abbott, Roche, and Danaher (Beckman Coulter, Radiometer). It competes as a specialized niche player in blood group serology and microbiology reagents, alongside other focused companies like Bio-Rad (serology), Grifols, and Immucor. Its differentiation is based on deep expertise in monoclonal antibodies, a broad portfolio in its niches, and high-quality, certified manufacturing.